US 12,376,802 B2
System and method for health monitoring including a user device and biosensor
Robert Steven Newberry, New Hope, AL (US)
Assigned to Trilinear BioVentures, LLC
Filed by Trilinear BioVentures, LLC, Huntsville, AL (US)
Filed on Dec. 18, 2020, as Appl. No. 17/127,266.
Application 17/127,266 is a continuation in part of application No. 15/718,721, filed on Sep. 28, 2017, granted, now 10,517,515, issued on Dec. 31, 2019.
Application 17/127,266 is a continuation in part of application No. 15/680,991, filed on Aug. 18, 2017, granted, now 9,968,289, issued on May 15, 2018.
Application 15/718,721 is a continuation of application No. 15/622,941, filed on Jun. 14, 2017, granted, now 9,788,767, issued on Oct. 17, 2017.
Application 17/127,266 is a continuation in part of application No. 15/462,700, filed on Mar. 17, 2017, granted, now 10,500,354, issued on Dec. 10, 2019.
Application 17/127,266 is a continuation in part of application No. 15/404,117, filed on Jan. 11, 2017, granted, now 10,932,727.
Application 15/462,700 is a continuation of application No. 15/400,916, filed on Jan. 6, 2017, granted, now 10,750,981, issued on Aug. 25, 2020.
Application 15/462,700 is a continuation of application No. 15/276,760, filed on Sep. 26, 2016, granted, now 9,636,457, issued on May 2, 2017.
Application 15/462,700 is a continuation of application No. 15/275,444, filed on Sep. 25, 2016, granted, now 9,642,538, issued on May 9, 2017.
Application 15/462,700 is a continuation of application No. 15/275,388, filed on Sep. 24, 2016, granted, now 9,642,578, issued on May 9, 2017.
Application 15/462,700 is a continuation of application No. 14/866,500, filed on Sep. 25, 2015, granted, now 10,321,860, issued on Jun. 18, 2019.
Claims priority of provisional application 62/457,138, filed on Feb. 9, 2017.
Prior Publication US 2021/0137466 A1, May 13, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 5/1455 (2006.01); A61B 5/00 (2006.01); A61B 5/01 (2006.01); A61B 5/0205 (2006.01); A61B 5/024 (2006.01); A61B 5/11 (2006.01); A61B 5/145 (2006.01); A61M 5/142 (2006.01); A61M 5/172 (2006.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01)
CPC A61B 5/7278 (2013.01) [A61B 5/0022 (2013.01); A61B 5/01 (2013.01); A61B 5/0205 (2013.01); A61B 5/02416 (2013.01); A61B 5/1118 (2013.01); A61B 5/14532 (2013.01); A61B 5/14546 (2013.01); A61B 5/1455 (2013.01); A61B 5/14551 (2013.01); A61B 5/14552 (2013.01); A61B 5/4839 (2013.01); A61B 5/4845 (2013.01); A61B 5/6817 (2013.01); A61B 5/7275 (2013.01); A61B 5/742 (2013.01); A61B 5/743 (2013.01); A61M 5/14248 (2013.01); A61M 5/1723 (2013.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); A61B 5/0008 (2013.01); A61B 5/6826 (2013.01); A61B 2560/0223 (2013.01); A61M 2205/3303 (2013.01); A61M 2205/3313 (2013.01); A61M 2205/3368 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/505 (2013.01); A61M 2230/06 (2013.01)] 20 Claims
OG exemplary drawing
 
1. User equipment, comprising:
a display;
at least one transceiver configured to communicate with an external biosensor, wherein the at least one transceiver receives biosensor data from the biosensor, wherein the biosensor data includes a first photoplethysmography (PPG) signal at a first wavelength of light and a second PPG signal at a second wavelength of light;
at least one processing circuit and at least one memory device, wherein the at least one memory device stores instructions which when executed by the at least one processing device, causes the user equipment to:
process the biosensor data to determine a relative alternating current (AC) component and a direct current (DC) component of the first wavelength of light and the second wavelength of light;
determine a level of nitric oxide (NO) in blood flow based on the relative AC component and the DC component of the first wavelength of light and the second wavelength of light; and
generate a graphical user interface (GUI) that displays the biosensor data on the display of the user equipment.